发明名称 |
Human protein tyrosine phosphatase inhibitors and methods of use |
摘要 |
The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. |
申请公布号 |
US9126958(B2) |
申请公布日期 |
2015.09.08 |
申请号 |
US201414569106 |
申请日期 |
2014.12.12 |
申请人 |
AERPIO THERAPEUTICS, INC. |
发明人 |
Gray Jeffrey Lyle;Amarasinghe Kande K. D.;Clark Cynthia Monesa;Nichols Ryan Matthew;Maier Matthew B. |
分类号 |
A61K31/4965;A61K31/497;A61K31/44;A61K31/425;C07D277/28;C07D417/04;C07D277/60 |
主分类号 |
A61K31/4965 |
代理机构 |
Wilson Sonsini Goodrich & Rosati |
代理人 |
Wilson Sonsini Goodrich & Rosati |
主权项 |
1. A compound of the formula: R is a thiazolyl group that is substituted or unsubstituted; R1 is alkyl, phenyl, or benzyl, any of which is substituted or unsubstituted, or hydrogen; R2 is alkyl or alkoxy; and R3 is hydrogen or alkyl,or a pharmaceutically-acceptable salt thereof. |
地址 |
Cincinnati OH US |